Back to catalog
Metabolic
Emerging evidenceRetatrutide
Triple agonist (GLP-1, GIP, glucagon) studied in metabolic trials.
Mechanism summary
Studied for triple incretin/glucagon receptor activation.
Emerging ResearchHuman Data Available
Pathways connected